Cantor Fitzgerald Upgrades Seattle Genetics (SGEN) to Hold

Go back to Cantor Fitzgerald Upgrades Seattle Genetics (SGEN) to Hold

Cowen Starts Seattle Genetics (SGEN) at Market Perform

November 4, 2014 7:27 AM EST

Cowen initiated coverage on Seattle Genetics (NASDAQ: SGEN) with a Market Perform rating.

For an analyst ratings summary and ratings history on Seattle Genetics click here. For more ratings news on Seattle Genetics click here.

Shares of Seattle Genetics closed at $37.25 yesterday.

... More

Seattle Genetics (SGEN) Tops Q3 EPS by 11c

October 30, 2014 5:08 PM EDT

Seattle Genetics (NASDAQ: SGEN) reported Q3 EPS of ($0.13), $0.11 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $75.8 million versus the consensus estimate of $66.9 million.

For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.

... More